Stepan (SCL) Cash & Equivalents (2010 - 2025)

Stepan has reported Cash & Equivalents for 16 years, with the latest figure at $132.7 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 33.13% year-over-year to $132.7 million; the trailing twelve-month figure through Dec 2025 stood at $132.7 million (up 33.13% YoY), and the FY2025 full-year result was $132.7 million, up 33.13% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $132.7 million, up from $118.5 million in the prior quarter.
• The five-year high for Cash & Equivalents was $236.0 million in Q1 2022, with the low at $88.9 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $137.7 million across 5 years, with a median of $128.4 million in 2021.
• Annual changes were most pronounced in 2021 — Cash & Equivalents tumbled 66.09% — and 2022, when it jumped 57.39%.
• Stepan's Cash & Equivalents stood at $159.2 million in 2021, then climbed by 9.15% to $173.8 million in 2022, then slipped by 25.28% to $129.8 million in 2023, then decreased by 23.23% to $99.7 million in 2024, then jumped by 33.13% to $132.7 million in 2025.
• The last three Cash & Equivalents figures came in at $132.7 million (Q4 2025), $118.5 million (Q3 2025), and $88.9 million (Q2 2025), per Business Quant data.